FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to novel compounds of formula (V), compounds of formula (IX), compounds of formula (XIII) or their tautomers or pharmaceutically acceptable salts, which are capable of inducing Hsp70, as well as to pharmaceutical composition, which contains claimed compounds.
Value of substituents in formulas (V), (IX) and (XIII) are such, as claimed in invention formula.
EFFECT: obtaining pharmaceutically acceptable salts, which have possibility of inducing Hsp70.
12 cl, 12 ex, 36 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USING AS INHIBITORS OF ALIPHATIC ACIDS OXIDATION | 2002 |
|
RU2300533C2 |
| PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
| SPIROINDOLINONE DERIVATIVES | 2007 |
|
RU2435771C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| ANALOGUES OF BENZOQUINONE-CONTAINING ANSAMYCINS (VERSIONS), METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION (VERSIONS) AND CANCER TREATMENT METHOD (VERSIONS) | 2004 |
|
RU2484086C9 |
| PREPARATION COMPRISING INHIBITOR OF HETEROTRIMERIC G PROTEINS SIGNAL TRANSDUCTION IN COMBINATION WITH OTHER CYTOSTATIC AGENT FOR THERAPEUTIC USING IN CANCER TREATMENT | 2000 |
|
RU2298417C2 |
| BENZOTHIEPINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC STATE | 1997 |
|
RU2202549C2 |
| METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
| THERAPEUTIC COMPOSITIONS OF 4'-HALOGEN-CONTAINING NUCLEOTIDES AND NUCLEOSIDES AND USE THEREOF | 2019 |
|
RU2819040C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
